Basic Information
RNALocate ID: RLID:11001789
RNA Symbol: hsa-miR-142-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-142-3p
RNA ID: miRBase:MIMAT0000434
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 22427800
Tissue/Cell Line: Serum
Method: qRT-PCR
Description: The miRNAs tested in serum and saliva samples are shown in Table 1. These miRNAs were selected because they are either ubiquitously expressed or have been reported as biomarkers (Table 1). The relative concentration of these microRNAs was determined by calculating the difference of Ct values between the exosome samples and the exosome-depleted supernatant. A 1-unit difference in the Ct value between the miRNAs isolated from the exosomal pellet or supernatant represents a 2-fold difference in the amount of input miRNA. Data are collected from Table 1: List of miRNAs tested in serum and saliva samples.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001786 Endoplasmic reticulum membrane Cortical tissue 32451872
RLID:11001787 Exosome B cell line (Raji)|Primary dendritic cells|T cell line (J77) 21505438
RLID:11001788 Exosome Breast milk 22211110
RLID:11001790 Exosome Brain tissue 23382797
RLID:11001791 Exosome Plasma 23663360
RLID:11001792 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001794 Microvesicle Plasma 19951903
RLID:11001795 Microvesicle Liver resident stem cells 20668554
RLID:11001796 Microvesicle Hepatoma cells 23771658
RLID-D:11000084 Exosome B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Lymphoma tissue|Mast cells
RLID-D:11000362 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-142-3p Mantle cell lymphoma MNDR-E-MI-13915
MNDR hsa-miR-142-3p Splenic marginal zone lymphoma MNDR-E-MI-13916
MNDR hsa-miR-142-3p Multiple sclerosis chronic progressive MNDR-E-MI-13917
MNDR hsa-miR-142-3p Oral squamous cell carcinoma MNDR-E-MI-13918
MNDR hsa-miR-142-3p Medulloblastoma MNDR-E-MI-13919
MNDR hsa-miR-142-3p B cell lymphoma of malt type MNDR-E-MI-13920
MNDR hsa-miR-142-3p Uterine corpus endometrial carcinoma MNDR-E-MI-13921
MNDR hsa-miR-142-3p Lymphoma MNDR-E-MI-13922
MNDR hsa-miR-142-3p Lymphoma non-hodgkin MNDR-E-MI-13923
MNDR hsa-miR-142-3p Estrogen-receptor positive breast cancer MNDR-E-MI-13924
MNDR hsa-miR-142-3p Estrogen-receptor negative breast cancer MNDR-E-MI-13925
MNDR hsa-miR-142-3p Progesterone-receptor positive breast cancer MNDR-E-MI-13926
MNDR hsa-miR-142-3p Progesterone-receptor negative breast cancer MNDR-E-MI-13927
MNDR hsa-miR-142-3p Her2-receptor positive breast cancer MNDR-E-MI-13928
MNDR hsa-miR-142-3p Breast cancer luminal MNDR-E-MI-13929
MNDR hsa-miR-142-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-13930
MNDR hsa-miR-142-3p Dermatomyositis MNDR-E-MI-13931
MNDR hsa-miR-142-3p Prostate cancer MNDR-E-MI-13932
MNDR hsa-miR-142-3p Hirschsprung disease MNDR-E-MI-13933
MNDR hsa-miR-142-3p Gastric cancer MNDR-E-MI-13934
MNDR hsa-miR-142-3p Pre-eclampsia MNDR-E-MI-13935
MNDR hsa-miR-142-3p Alzheimer disease MNDR-E-MI-13936
MNDR hsa-miR-142-3p Sarcoma MNDR-E-MI-13937
MNDR hsa-miR-142-3p Dysautonomia familial MNDR-E-MI-13938
MNDR hsa-miR-142-3p Leukemia MNDR-E-MI-13939
MNDR hsa-miR-142-3p Huntington disease MNDR-E-MI-13940
MNDR hsa-miR-142-3p Chorea MNDR-E-MI-13941
MNDR hsa-miR-142-3p Cardiovascular disease MNDR-E-MI-13942
MNDR hsa-miR-142-3p Moyamoya disease MNDR-E-MI-13943
MNDR hsa-miR-142-3p Lung cancer MNDR-E-MI-13944
MNDR hsa-miR-142-3p Down syndrome MNDR-E-MI-13945
MNDR hsa-miR-142-3p Parkinson disease MNDR-E-MI-13946
MNDR hsa-miR-142-3p Basal-like breast cancer MNDR-E-MI-13947
MNDR hsa-miR-142-3p Thyroid cancer MNDR-E-MI-13948
MNDR hsa-miR-142-3p Pituitary neoplasms MNDR-E-MI-13949
MNDR hsa-miR-142-3p Pancreatic cancer MNDR-E-MI-13950
MNDR hsa-miR-142-3p Melanoma MNDR-E-MI-13951
MNDR hsa-miR-142-3p Rectum adenocarcinoma MNDR-E-MI-13952
MNDR hsa-miR-142-3p Colon cancer MNDR-E-MI-13953
MNDR hsa-miR-142-3p Ischemic attack transient MNDR-E-MI-13954
MNDR hsa-miR-142-3p Colon adenocarcinoma MNDR-E-MI-13955
MNDR hsa-miR-142-3p Multiple sclerosis MNDR-E-MI-13956
MNDR hsa-miR-142-3p Relapsing-remitting multiple sclerosis MNDR-E-MI-13957
MNDR hsa-miR-142-3p Familial ovarian cancer MNDR-E-MI-13958
MNDR hsa-miR-142-3p Asthma MNDR-E-MI-13959
MNDR hsa-miR-142-3p Endometriosis MNDR-E-MI-13960
MNDR hsa-miR-142-3p Carcinoma ductal breast MNDR-E-MI-13961
MNDR hsa-miR-142-3p Glioblastoma MNDR-E-MI-13962
MNDR hsa-miR-142-3p Astrocytoma MNDR-E-MI-13963
MNDR hsa-miR-142-3p Malignant glioma MNDR-E-MI-13964
MNDR hsa-miR-142-3p Amyotrophic lateral sclerosis MNDR-E-MI-13965
MNDR hsa-miR-142-3p Osteosarcoma MNDR-E-MI-13966
MNDR hsa-miR-142-3p Liposarcoma MNDR-E-MI-13967
MNDR hsa-miR-142-3p Breast carcinoma MNDR-E-MI-13968
MNDR hsa-miR-142-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-13969
MNDR hsa-miR-142-3p Meningioma MNDR-E-MI-13970
MNDR hsa-miR-142-3p Uterine cancer MNDR-E-MI-13971
MNDR hsa-miR-142-3p Gastric adenocarcinoma MNDR-E-MI-13972
MNDR hsa-miR-142-3p Cervical squamous cell carcinoma MNDR-E-MI-13973
MNDR hsa-miR-142-3p Pituitary adenoma MNDR-E-MI-13974
MNDR hsa-miR-142-3p Lung squamous cell carcinoma MNDR-E-MI-13975
MNDR hsa-miR-142-3p Carcinoma lung non-small-cell MNDR-E-MI-13976
MNDR hsa-miR-142-3p Lung adenocarcinoma MNDR-E-MI-13977
MNDR hsa-miR-142-3p Thyroid carcinoma MNDR-E-MI-13978
MNDR hsa-miR-142-3p Bladder urothelial carcinoma MNDR-E-MI-13979
MNDR hsa-miR-142-3p Pancreatic adenocarcinoma MNDR-E-MI-13980
MNDR hsa-miR-142-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-13981
MNDR hsa-miR-142-3p Carcinoma renal cell MNDR-E-MI-13982
MNDR hsa-miR-142-3p Kidney renal papillary cell carcinoma MNDR-E-MI-13983
MNDR hsa-miR-142-3p Clear cell renal cell carcinoma MNDR-E-MI-13984
MNDR hsa-miR-142-3p Cholangiocarcinoma MNDR-E-MI-13985
MNDR hsa-miR-142-3p Prolactinoma MNDR-E-MI-13986
MNDR hsa-miR-142-3p Head and neck squamous cell carcinoma MNDR-E-MI-13987
MNDR hsa-miR-142-3p Testicular germ cell cancer MNDR-E-MI-13988
MNDR hsa-miR-142-3p Kidney diseases MNDR-E-MI-13989
MNDR hsa-miR-142-3p T-cell acute lymphoblastic leukemia MNDR-E-MI-13990
MNDR hsa-miR-142-3p Fibromyalgia MNDR-E-MI-13991
MNDR hsa-miR-142-3p Breast invasive carcinoma MNDR-E-MI-13992
MNDR hsa-miR-142-3p Hepatocellular carcinoma MNDR-E-MI-13993
MNDR hsa-miR-142-3p Embryonal cancer MNDR-E-MI-13994
MNDR hsa-miR-142-3p Familiar ovarian carcinoma MNDR-E-MI-13995
MNDR hsa-miR-142-3p B-cell lymphoma MNDR-E-MI-13996
MNDR hsa-miR-142-3p Rheumatoid arthritis MNDR-E-MI-13997
MNDR hsa-miR-142-3p Osteoarthritis MNDR-E-MI-13998
MNDR hsa-miR-142-3p Hodgkin lymphoma MNDR-E-MI-13999
MNDR hsa-miR-142-3p Ulcerative colitis MNDR-E-MI-14000
MNDR hsa-miR-142-3p Burkitt lymphoma MNDR-E-MI-14001
MNDR hsa-miR-142-3p Tonsil cancer MNDR-E-MI-14002
MNDR hsa-miR-142-3p Neuromyelitis optica MNDR-E-MI-14003
MNDR hsa-miR-142-3p Psoriasis MNDR-E-MI-14004
MNDR hsa-miR-142-3p Skin cutaneous melanoma MNDR-E-MI-14005
MNDR hsa-miR-142-3p Skin melanoma MNDR-E-MI-14006
MNDR hsa-miR-142-3p Acute myeloid leukemia MNDR-E-MI-14007
MNDR hsa-miR-142-3p Colorectal cancer MNDR-E-MI-14008
MNDR hsa-miR-142-3p Nasopharyngeal carcinoma MNDR-E-MI-14009
MNDR hsa-miR-142-3p Nasopharynx carcinoma MNDR-E-MI-14010
MNDR hsa-miR-142-3p Multiple myeloma MNDR-E-MI-14011
MNDR hsa-miR-142-3p Acute lymphoblastic leukemia MNDR-E-MI-14012
MNDR hsa-miR-142-3p Ependymoma MNDR-E-MI-14013
MNDR hsa-miR-142-3p Nasopharyngeal cancer MNDR-E-MI-14014
MNDR hsa-miR-142-3p Prostatic neoplasms MNDR-E-MI-14015
MNDR hsa-miR-142-3p Aids dementia complex MNDR-E-MI-14016
MNDR hsa-miR-142-3p Cerebral hemorrhage traumatic MNDR-E-MI-14017
MNDR hsa-miR-142-3p Intracranial hemorrhage hypertensive MNDR-E-MI-14018
MNDR hsa-miR-142-3p Stroke lacunar MNDR-E-MI-14019
MNDR hsa-miR-142-3p Breast cancer her3+ negative MNDR-E-MI-14020
MNDR hsa-miR-142-3p Multiple sclerosis susceptibility MNDR-E-MI-14021
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCG2 Homo sapiens RR00024737
TOP